Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Laurence J.N. Cooper(The University of Texas MD Anderson Cancer Center)
Cited by 499
Related Papers
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
|Biology of Blood and Marrow Transplantation|2010|522
CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances<i>In vivo</i>Persistence and Antitumor Efficacy of Adoptively Transferred T Cells
|Cancer Research|2006|487
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
|Proceedings of the National Academy of Sciences|2016|452